Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.

Kautz-Freimuth, Sibylle; Redaèlli, Marcus; Isselhard, Anna; Shukri, Arim; Vodermaier, Andrea; Rhiem, Kerstin; Schmutzler, Rita; Stock, Stephanie

Kautz-Freimuth, Sibylle; Redaèlli, Marcus; Isselhard, Anna; Shukri, Arim; Vodermaier, Andrea; Rhiem, Kerstin; Schmutzler, Rita; Stock, Stephanie.

Afiliação

Kautz-Freimuth S; Institute of Health Economics and Clinical Epidemiology, The University Hospital of Cologne, Gleueler Straße 176-178, 50935, Cologne, Germany. sibylle.kautz-freimuth@uk-koeln.de.
Redaèlli M; Institute of Health Economics and Clinical Epidemiology, The University Hospital of Cologne, Gleueler Straße 176-178, 50935, Cologne, Germany.
Isselhard A; Institute of Health Economics and Clinical Epidemiology, The University Hospital of Cologne, Gleueler Straße 176-178, 50935, Cologne, Germany.
Shukri A; Institute of Health Economics and Clinical Epidemiology, The University Hospital of Cologne, Gleueler Straße 176-178, 50935, Cologne, Germany.
Vodermaier A; Institute of Health Economics and Clinical Epidemiology, The University Hospital of Cologne, Gleueler Straße 176-178, 50935, Cologne, Germany.
Rhiem K; School of Population and Public Health, The University of British Columbia, 2206 East Mall, Vancouver, BC, C6T 1Z3, Canada.
Schmutzler R; Centre for Familial Breast and Ovarian Cancer, Centre for Integrated Oncology (CIO), Faculty of Medicine and The University Hospital of Cologne, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
Stock S; Centre for Familial Breast and Ovarian Cancer, Centre for Integrated Oncology (CIO), Faculty of Medicine and The University Hospital of Cologne, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Trials ; 23(1): 157, 2022 Feb 16.

Article em En | MEDLINE | ID: mdl-35172875

Assuntos

Proteína BRCA1; Proteína BRCA2; Neoplasias da Mama; Neoplasias Ovarianas; Proteína BRCA1/genética; Proteína BRCA2/genética; Neoplasias da Mama/genética; Neoplasias da Mama/prevenção & controle; Técnicas de Apoio para a Decisão; Feminino; Alemanha; Humanos; Mastectomia; Mutação; Neoplasias Ovarianas/genética; Neoplasias Ovarianas/prevenção & controle; Ensaios Clínicos Controlados Aleatórios como Assunto

Palavras-chave

BRCA1 mutation; BRCA2 mutation; Decision aid; Decision-making; Evaluation study; Familial breast and ovarian cancer; Hereditary breast and ovarian cancer (HBOC); Patient-centred care; Preference-sensitive decisions; Preventive measures

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Proteína BRCA1 / Proteína BRCA2 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google